Labcorp Holdings Files 8-K
Ticker: LH · Form: 8-K · Filed: Sep 3, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing
Related Tickers: LH
TL;DR
Labcorp filed an 8-K on Sept 3rd for disclosures and exhibits.
AI Summary
On September 3, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it establishes the filing date and company information.
Why It Matters
This filing indicates ongoing reporting requirements for Labcorp Holdings Inc. to the SEC, ensuring transparency for investors regarding company disclosures and financial statements.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- September 3, 2024 (date) — Filing Date
- 358 South Main Street Burlington, North Carolina 27215 (address) — Principal Executive Offices
- 336 - 229-1127 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for LABCORP HOLDINGS INC.?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
On what date was this 8-K filing made?
The filing was made on September 3, 2024.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is LABCORP HOLDINGS INC.
Where are LABCORP HOLDINGS INC.'s principal executive offices located?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the telephone number for LABCORP HOLDINGS INC.?
The telephone number is 336 - 229-1127.
Filing Stats: 405 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2024-09-03 16:15:26
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240903.htm (8-K) — 25KB
- formpr9324ex991bairdhcconf.htm (EX-99.1) — 5KB
- lc2020logov2a.gif (GRAPHIC) — 5KB
- 0000920148-24-000106.txt ( ) — 158KB
- lh-20240903.xsd (EX-101.SCH) — 2KB
- lh-20240903_lab.xml (EX-101.LAB) — 21KB
- lh-20240903_pre.xml (EX-101.PRE) — 12KB
- lh-20240903_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Members of Labcorp Holding Inc.'s executive management team will participate in a presentation at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 3:10 p.m. ET.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated September 3, 2024 issued by Labcorp Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary September 3, 2024